Cipla, Serum Institute launch Hepatitis B vaccine Industry-The Economic Times — February 17, 2017 comments off As per Cipla’s co-exclusive agreement with SII, the former will market the vaccine for adults while the latter will market it for adults and children.
As per Cipla’s co-exclusive agreement with SII, the former will market the vaccine for adults while the latter will market it for adults and children.